This is a Validated Antibody Database (VAD) review about human MTA2, based on 5 published articles (read how Labome selects the articles), using MTA2 antibody in all methods. It is aimed to help Labome visitors find the most suited MTA2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
MTA2 synonym: MTA1L1; PID; metastasis-associated protein MTA2; MTA1-L1 protein; metastasis -associated gene 1-like 1; metastasis associated gene family, member 2; metastasis-associated 1-like 1; metastasis-associated protein 2; p53 target protein in deacetylase complex
Santa Cruz Biotechnology
mouse monoclonal (F-9) |
| Santa Cruz Biotechnology MTA2 antibody (Santa Cruz, sc- 55566) was used in western blot on human samples at 1:300 (fig 3c). Neuroreport (2016) ncbi |
mouse monoclonal (F-9) |
| Santa Cruz Biotechnology MTA2 antibody (Santa Cruz, sc-55566) was used in western blot on human samples (fig 6). PLoS ONE (2015) ncbi |
Bethyl
rabbit polyclonal |
| Bethyl MTA2 antibody (Bethyl, A300-395A) was used in immunoprecipitation on mouse samples (fig 2) and in western blot on mouse samples (fig s2). Mol Cell (2015) ncbi |
Invitrogen
rabbit polyclonal |
| In order to determine how CHD5 suppresses tumors, Invitrogen MTA2 antibody (Thermo Sci., PA1-41581) was used in western blot on human samples . PLoS ONE (2014) ncbi |
Sigma-Aldrich
rabbit polyclonal |
| Sigma-Aldrich MTA2 antibody (Sigma, M1194) was used in western blot on human samples (fig 1e). J Biol Chem (2014) ncbi |
Articles Reviewed
- Pan Y, Liang W, Zhao X, Liu L, Qing Y, Li Y. miR-548b inhibits the proliferation and invasion of malignant gliomas by targeting metastasis tumor-associated protein-2. Neuroreport. 2016;27:1266-1273 pubmed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments